Signal Transduction Pathways
E. Sanders-Bush and H. Canton
Department of Pharmacology
Vanderbilt University School of Medicine
Nashville, Tennessee 37232
1. Abdel-Baset H, Bozovic V, Szyf M, Albert PR. Conditional transformation mediated via a pertussis toxin-sensitive receptor signalling pathway. Mol Endocrinol 1992;6:730–740.
2. Adham N, Ellerbrock B, Hartig P, Weinshank RL, Branchek T. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system. Mol Pharmacol 1993;43:427–433.
3. Aghajanian GK. Serotonin-induced inward current in rat facial motoneurons: evidence for mediation by G proteins but not protein kinase C. Brain Res 1990;524:171–174.
4. Akiyoshi J, Hough C, Chuang D-M. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation. Mol Pharmacol 1993;43:349–355.
5. Andrade R. Enhancement of b-adrenergic responses by Gi-linked receptors in rat hippocampus. Neuron 1993;10:83–88.
6. Andrade R, Chaput Y. 5-Hydroxytryptamine 4-like receptors mediate the slow excitatory response to serotonin in rat hippocampus. J Pharmacol Exp Ther 1991;257:930–937.
7. Andrade R, Malenka RC, Nicoll RA. A G protein couples serotonin and GABA B receptors to the same channels in hippocampus. Science 1986;234:1261–1265.
8. Apud JA, Grayson DR, De Erausquin E, Costa E. Pharmacological characterization of regulation of phosphoinositide metabolism by recombinant 5-HT2 receptors of the rat. Neuropharmacology 1992;31:1–8.
9. Araneda R, Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 1991;40:399–412.
9a. Barker E, Westphal RS, Schmidt D, Sanders-Bush E. Constitutively active 5-hydroxytryptamine2c receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 1994; 269: 11687–11690.
10. Birnbaumer L. Receptor-to-effector signaling through G proteins: roles for bg dimers as well as a subunits. Cell 1992;71:1069–1072.
11. Blier P. Terminal serotonin autoreceptor function in the rat hippocampus is not modified by pertussis and cholera toxins. Naunyn Schmiedebergs Arch Pharmacol 1991;344:160–166.
12. Bockaert J, Fozard JR, Dumuis A, Clarke DE. The 5-HT4 receptor: a place in the sun. Trends Pharmacol Sci 1992;13:141–145.
13. Boddeke HWGM, Fargin A, Raymond JR, Schoeffter P, Hoyer D. Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn Schmiedebergs Arch Pharmacol 1992;345:257–263.
14. Branchek T, Adham N, Macchi M, Kao H-T, Hartig PR. [3H]DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H]ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Mol Pharmacol 1990;38:604–609.
15. Burris KD, Breeding M, Sanders-Bush E. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. J Pharmacol Exp Ther 1991;258:891–896.
16. Claustre Y, Bénavidès J, Scatton B. 5-HT1A receptor agonists inhibit carbachol-induced stimulation of phosphoinositide turnover in the rat hippocampus. Eur J Pharmacol 1988;149:149–153.
17. Claustre Y, Bénavidès J, Scatton B. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus. J Neurochem 1991;56:1276–1285.
18. Claustre Y, Rouquier L, Scatton B. Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat. J Pharmacol Exp Ther 1988;244:1051–1056.
19. Claustre Y, Eudeline B, Bénavidès J, Scatton B. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus. Eur J Pharmacol 1992;225:37–41.
20. Dascal N, Ifune C, Hopkins R, et al. Involvement of a GTP-binding protein in mediation of serotonin and acetylcholine responses in Xenopus oocytes injected with rat brain messenger RNA. Mol Brain Res 1986;1:201–209.
21. Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 1988; 34:880–887.
22. Edwards E, Harkins K, Ashby CR Jr, Wang RY. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositide hydrolysis in the rat fronto-cingulate and entorhinal cortices. J Pharmacol Exp Ther 1991;256:1025–1032.
23. Enna SJ, Karbon EW. Receptor regulation: evidence for a relationship between phospholipid metabolism and neurotransmitter receptor-mediated cAMP formation in brain. Trends Pharmacol Sci 1987;8:21–24.
24. Esterle TM, Sanders-Bush E. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium. J Neurosci 1992;12:4775–4782.
25. Fargin A, Yamamoto K, Cotecchia S, et al. Dual coupling of the cloned 5-HT1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same Gi protein. Cell Signal 1991;3:547–557.
26. Fargin A, Raymond JR, Regan JW, Cotecchia S, Lefkowitz RJ, Caron MG. Effector coupling mechanisms of the cloned 5-HT1A receptor. J Biol Chem 1989;264:14848–14852.
27. Federman AD, Conklin BR, Schrader KA, Reed RR, Bourne HR. Hormonal stimulation of adenyl cyclase through Gi-protein bg subunits. Nature 1992;356:159–161.
28. Felder CC, Kanterman RY, Ma AL, Axelrod J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci USA 1990;87:2187–2191.
29. Foguet M, Hoyer D, Pardo LA, et al. Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J 1992;11:3481–3487.
30. Galzin AM, Langer SZ. Modulation of 5-HT release by presynaptic inhibitory and facilitatory 5-HT receptors in brain slices. In: Langer SZ, Galzin AM, Costentin J, eds. Presynaptic receptors and neuronal transporters. Oxford: Pergamon Press, 1991;82:59–62.
31. Hamon M, Lanfumey L, El Mestikawy S, et al. The main features of central 5-HT1 receptors. Neuropsychopharmacology 1990;3:349–360.
32. Hansson E, Simonsson P, Alling C. Interactions between cyclic AMP and inositol phosphate transduction systems in astrocytes in primary culture. Neuropharmacology 1990;29:591–598.
33. Hartig PR, Hoffman BJ, Kaufman MJ, Hirata F. The 5-HT1C receptor. In: Whitaker-Azmitia PM, Peroutka SJ, eds. The neuropharmacology of serotonin. New York: The New York Academy of Sciences, 1990;149–167.
34. Hoger JH, Walter AE, Vance D, Yu L, Lester HA, Davidson N. Modulation of a cloned mouse brain potassium channel. Neuron 1991;6:227–236.
35. Hope AG, Downie DL, Sutherland L, Lambert JJ, Peters JA, Burchell B. Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit. Eur J Pharmacol 1993;245:187–192.
36. Humphrey PPA, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 1993;14:233–236.
37. Hung BCP, Loo DDF, Wright EM. Regulation of mouse choroid plexus apical Cl- and K+ channels by serotonin. Brain Res 1993;617:285–295.
38. Ivins KJ, Molinoff PB. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol Pharmacol 1990;37:622–630.
39. Julius D, Livelli TJ, Jessell TM, Axel R. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 1989;244:1057–1062.
40. Julius D, Huang KN, Livelli TJ, Axel R, Jessell TM. The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci USA 1990;87:928–932.
41. Kahan C, Julius D, Pouysségur J, Seuwen K. Effects of 5-HT1C-receptor expression on cell proliferation control in hamster fibroblasts: serotonin fails to induce a transformed phenotype. Exp Cell Res 1992;200:523–527.
42. Kavanaugh WM, Williams LT, Ives HE, Coughlin SR. Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol Endocrinol 1988;2:599–605.
43. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 1991;353:43–48.
44. Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M. Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. Mol Pharmacol 1992;42:549–557.
45. Liscovitch M. Crosstalk among multiple signal-activated phospholipases. Trends Biochem Sci 1992;17:393–399.
46. Liu YF, Albert PR. Cell-specific signaling of the 5-HT1A receptor. J Biol Chem 1991;266:23689–23697.
47. Lübbert H, Snutch TP, Dascal N, Lester HA, Davidson N. Rat brain 5-HT1C receptors are encoded by a 5–6 kbase mRNA size class and are functionally expressed in injected Xenopus oocytes. J Neurosci 1987;7:1159–1165.
48. Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991;254:432–437.
49. Mayer, SE, and Sanders-Bush, E. 5HT2A and 5HT2C receptors linked to Na+, K+ and Cl- co-transport. Mol Pharmacol 1994;[in press].
50. Middleton JP, Raymond JR, Whorton AR, Dennis VW. Short-term regulation of Na+/K+ adenosine triphosphatase by recombinant human serotonin 5-HT1A receptor expressed in HeLa cells. J Clin Invest 1990;86:1799–1805.
51. Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993;43:320–327.
52. Murphy TJ, Bylund DB. Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum. J Pharmacol Exp Ther 1989;249:535–543.
53. Nilsson M, Hansson E, Rönnbäck L. Heterogeneity among astroglial cells with respect to 5HT-evoked cytosolic Ca2+ responses. A microspectrofluorimetric study on single cells in primary culture. Life Sciences 1991;49:1339–1350.
54. Ogura A, Ozaki K, Kudo Y, Amano T. Cytosolic calcium elevation and cGMP production induced by serotonin in a clonal cell of glial origin. J Neurosci 1986;6:2489–2494.
55. Panicker MM, Parker I, Miledi R. Receptors of the serotonin 1C subtype expressed from cloned DNA mediate the closing of K+ membrane channels encoded by brain mRNA. Proc Natl Acad Sci USA 1991;88:2560–2562.
56. Peters JA, Malone HM, Lambert JJ. Recent advances in the electrophysiological characterization of 5HT3 receptors. Trends Pharmacol Sci 1992;13:391–397.
57. Pierce PA, Peroutka SJ. Evidence for distinct 5-hydroxytryptamine2 binding site subtypes in cortical membrane preparations. J Neurochem 1989;52:656–658.
58. Pratt GD, Bowery NG. The 5-HT3 receptor ligand, [3H]BRL 43694, binds to presynaptic sites in the nucleus tractus solitarius of the rat. Neuropharmacology 1989;28:1367–1376.
59. Pritchett DB, Bach AWJ, Wozny M, Taleb O, Dal Toso R, Shih JC, Seeburg PH. Structure and functional expression of cloned rat serotonin 5-HT-2 receptor. EMBO J 1988;7:4135–4140.
60. Raymond JR, Albers FJ, Middleton JP. Functional expression of human 5-HT1A receptors and differential coupling to second messengers in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 1992;346:127–137.
61. Raymond JR, Fargin A, Middleton JP, et al. The human 5-HT1A receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase C. J Biol Chem 1989;264:21943–21950.
62. Reiser G. Mechanism of stimulation of cyclic-GMP level in a neuronal cell line mediated by serotonin (5-HT3) receptors. Eur J Biochem 1990;189:547–552.
63. Rhee SG, Choi KD. Regulation of inositol phospholipid-specific phospholipase C isozymes. J Biol Chem 1992;267:12393–12396.
64. Sanders-Bush E. 5-HT receptors coupled to phosphoinositide hydrolysis. In: Sanders-Bush E, ed. The serotonin receptors. Clifton, NJ: Humana Press, 1988;181–198.
65. Seuwen K, Magnaldo I, Pouysségur J. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature 1988;335:254–256.
66. Sundaram H, Newman-Tancredi A, Strange PG. Characterization of recombinant human serotonin 5HT1A receptors expressed in chinese hamster ovary cells. Biochem Pharmacol 1993;45:1003–1009.
67. Surprenant A, Horstman DA, Akbarali H, Limbird LL. A point mutation of the a2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992;257:977–980.
68. Tang W-J, Gilman A. Type-specific regulation of adenylyl cyclase by G protein bg subunits. Science 1991;254:1500–1503.
69. Teitler M, Leonhardt S, Weisberg EL, Hoffman BJ. 4-[125I]Iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5-HT2) receptors in mammalian cells transfected with a rat 5-HT2 receptor subtypes. Mol Pharmacol 1990;38:594–598.
70. Tohda M, Nakamura J, Hidaka H, Nomura Y. Inhibitory effects of KN-62, a specific inhibitor of Ca/calmodulin-dependent protein kinase II, on serotonin-evoked Cl- current and 36Cl- efflux in Xenopus oocytes. Neurosci Lett 1991;129:47–50.
71. Varrault A, Journot L, Audigier Y, Bockaert J. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase. Mol Pharmacol 1992;41:1007–1007.
72. Wang RY, Ashby CR Jr, Zhang JY. Functional roles of 5-HT3like receptors in the medial prefrontal cortex. Adv Biosci 1992; 85:81–96.
73. Yocca FD, Iben L, Meller E. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Mol Pharmacol 1992;41:1066–1072.
74. Zgombick JM, Beck SG, Mahle CD, Craddock-Royal B, Maayani S. Pertussis toxin-sensitive guanine nucleotide-binding protein(s) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies. Mol Pharmacol 1989;35:484–494.